pyruvaldehyde has been researched along with Dyslipidemia in 5 studies
Pyruvaldehyde: An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.
methylglyoxal : A 2-oxo aldehyde derived from propanal.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Body weight gain, fat deposits, dyslipidemia, hyperglycemia, and fatty liver were ameliorated by dietary genistein in both studies." | 3.91 | Dietary Genistein Inhibits Methylglyoxal-Induced Advanced Glycation End Product Formation in Mice Fed a High-Fat Diet. ( Sang, S; Wang, P; Zhao, Y, 2019) |
| "Glo-1 has a dual role in cancer as a tumour suppressor protein prior to tumour development and mediator of multi-drug resistance in cancer treatment, implicating dicarbonyl glycation of DNA in carcinogenesis and dicarbonyl-driven cytotoxicity in mechanism of action of anticancer drugs." | 2.53 | Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics. ( Rabbani, N; Thornalley, PJ; Xue, M, 2016) |
| "Childhood obesity is associated with insulin resistance (IR), increased levels of small dense low-density lipoprotein (sd-LDL) as well as with augmented hepatic de novo lipogenesis, which implies increased triose phosphate fluxes that may lead to increased methylglyoxal (MG) and its catabolic end product D-lactate." | 1.48 | Higher D-lactate levels are associated with higher prevalence of small dense low-density lipoprotein in obese adolescents. ( Bains, Y; Caccavello, R; Garay-Sevilla, ME; Gugliucci, A; Luevano-Contreras, C; Rodríguez-Mortera, R; Solorio-Meza, S, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rabbani, N | 2 |
| Xue, M | 2 |
| Weickert, MO | 1 |
| Thornalley, PJ | 2 |
| Rodríguez-Mortera, R | 1 |
| Luevano-Contreras, C | 1 |
| Solorio-Meza, S | 1 |
| Caccavello, R | 1 |
| Bains, Y | 1 |
| Garay-Sevilla, ME | 1 |
| Gugliucci, A | 1 |
| Zhao, Y | 1 |
| Wang, P | 1 |
| Sang, S | 1 |
| Francisco, FA | 1 |
| Barella, LF | 1 |
| Silveira, SDS | 1 |
| Saavedra, LPJ | 1 |
| Prates, KV | 1 |
| Alves, VS | 1 |
| Franco, CCDS | 1 |
| Miranda, RA | 1 |
| Ribeiro, TA | 1 |
| Tófolo, LP | 1 |
| Malta, A | 1 |
| Vieira, E | 1 |
| Palma-Rigo, K | 1 |
| Pavanello, A | 1 |
| Martins, IP | 1 |
| Moreira, VM | 1 |
| de Oliveira, JC | 1 |
| Mathias, PCF | 1 |
| Gomes, RM | 1 |
1 review available for pyruvaldehyde and Dyslipidemia
| Article | Year |
|---|---|
Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics.
Topics: Aging; Animals; Dyslipidemias; Glycation End Products, Advanced; Humans; Lactoylglutathione Lyase; N | 2016 |
1 trial available for pyruvaldehyde and Dyslipidemia
| Article | Year |
|---|---|
Reversal of Insulin Resistance in Overweight and Obese Subjects by
Topics: Adult; Blood Pressure; Body Mass Index; Carrier Proteins; Correlation of Data; Cross-Over Studies; D | 2021 |
3 other studies available for pyruvaldehyde and Dyslipidemia
| Article | Year |
|---|---|
Higher D-lactate levels are associated with higher prevalence of small dense low-density lipoprotein in obese adolescents.
Topics: Adolescent; Biomarkers; Body Mass Index; Carotid Intima-Media Thickness; Cross-Sectional Studies; Dy | 2018 |
Dietary Genistein Inhibits Methylglyoxal-Induced Advanced Glycation End Product Formation in Mice Fed a High-Fat Diet.
Topics: Adipose Tissue; Aldehyde Reductase; Animals; Diabetes Mellitus; Diet, High-Fat; Dietary Fats; Dyslip | 2019 |
Methylglyoxal treatment in lactating mothers leads to type 2 diabetes phenotype in male rat offspring at adulthood.
Topics: Adiposity; Administration, Oral; Animals; Diabetes Mellitus, Type 2; Dyslipidemias; Environmental Po | 2018 |